Restoring Vision Without Correction

Biologists from South Korea have developed a drug that triggers the regeneration of the eye's retina. The drug consists of antibodies that block the protein prospero homeobox 1 (Prox1). It is this protein that hinders the regeneration of the retina's nerves. During trials, the effect of blocking Prox1 lasted for 6 months or more. However, clinical trials on humans will only begin in 2028.